Background: Immunocompromised patients with acute diverticulitis are at increased risk of morbidity and mortality. The aim of this study was to compare clinical presentations, types of treatment, and outcomes between immunocompromised and immunocompetent patients with acute diverticulitis. Methods: We compared the data of patients with acute diverticulitis extracted from the Web-based International Registry of Emergency Surgery and Trauma (WIRES-T) from January 2018 to December 2021. First, two groups were identified: medical therapy (A) and surgical therapy (B). Each group was divided into three subgroups: nonimmunocompromised (grade 0), mildly to moderately (grade 1), and severely immunocompromised (grade 2). Results: Data from 482 patients were analyzed—229 patients (47.5%) [M:F = 1:1; median age: 60 (24–95) years] in group A and 253 patients (52.5%) [M:F = 1:1; median age: 71 (26–94) years] in group B. There was a significant difference between the two groups in grade distribution: 69.9% versus 38.3% for grade 0, 26.6% versus 51% for grade 1, and 3.5% versus 10.7% for grade 2 (p < 0.00001). In group A, severe sepsis (p = 0.027) was more common in higher grades of immunodeficiency. Patients with grade 2 needed longer hospitalization (p = 0.005). In group B, a similar condition was found in terms of severe sepsis (p = 0.002), quick Sequential Organ Failure Assessment score > 2 (p = 0.0002), and Mannheim Peritonitis Index (p = 0.010). A Hartmann’s procedure is mainly performed in grades 1–2 (p < 0.0001). Major complications increased significantly after a Hartmann’s procedure (p = 0.047). Mortality was higher in the immunocompromised patients (p = 0.002). Conclusions: Immunocompromised patients with acute diverticulitis present with a more severe clinical picture. When surgery is required, immunocompromised patients mainly undergo a Hartmann’s procedure. Postoperative morbidity and mortality are, however, higher in immunocompromised patients, who also require a longer hospital stay.
Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T) / Tartaglia, D.; Cremonini, C.; Annunziata, E.; Catena, F.; Sartelli, M.; Kirkpatrick, A. W.; Musetti, S.; Strambi, S.; Chiarugi, M.; Coccolini, F.; Salvetti, F.; Fugazzola, P.; Ceresoli, M.; Benedetti, F.; Elisa, N. G.; Litvin, A.; Lostoridis, E.; Ahmed, A. Y. Y. M.; Manatakis, D.; Negoi, I.; Ioannidis, O.; Uzunoglu, M. Y.; Tochie, J. N.; Cillara, N.; Tomadze, G.; Bala, M.; Isik, A.; Fonseca, V. C.; Bellanova, G.; Ghannam, W.; Yalkin, O.; Garcia, F. H.; Altintoprak, F.; Hadzhiev, D.; Chirica, M.; Zese, M.; Balalis, D.; Cui, Y.; Luppi, D.; Romeo, L.; Muratore, A.; Lunghi, E. G.; Yovtchev, Y.; Dimitrov, E.; Nikolopoulos, I.; Omerovic, M.; Zizzo, M.; Ugoletti, L.; Costa, G.; Scalzone, R.; Perrone, S.; Occhionorelli, S.; Nardi, M.; Gubbiotti, F.; Muhtaroglu, A.; Scaramuzzo, R.; Corte, H.; Yanez, C.; Zakaria, A. D.; Seretis, C.; Gelmini, R.; Pappalardo, V.; Paratore, F.; Sydorchuk, R.; Mulita, F.; Kara, Y.; Toma, E. A.; Vailas, M.; Sotiropoulou, M.; Elbahnasawy, M.; Sibilla, M. G.; Martines, G.; Goksoy, B.; Hadzhiev, D.; Parini, D.; Zaghi, C.; Podda, M.; Osipov, A.; Brisinda, G.; Gambino, G.; Doklestic, L. A. K.; Loncar, Z.; Micic, D.; Lesevic, I.; D'Agostino, F.; Garzali, I. U.; Caicedo, Y.; Marcela, L.; Marin, P. A. G.; Perivoliotis, K.; Ntentas, I.; Kuptsov, A.; Chowdhury, S.; Patel, T.. - In: TECHNIQUES IN COLOPROCTOLOGY. - ISSN 1123-6337. - 27:9(2023), pp. 747-757. [10.1007/s10151-023-02758-6]
Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T)
Gelmini R.;
2023
Abstract
Background: Immunocompromised patients with acute diverticulitis are at increased risk of morbidity and mortality. The aim of this study was to compare clinical presentations, types of treatment, and outcomes between immunocompromised and immunocompetent patients with acute diverticulitis. Methods: We compared the data of patients with acute diverticulitis extracted from the Web-based International Registry of Emergency Surgery and Trauma (WIRES-T) from January 2018 to December 2021. First, two groups were identified: medical therapy (A) and surgical therapy (B). Each group was divided into three subgroups: nonimmunocompromised (grade 0), mildly to moderately (grade 1), and severely immunocompromised (grade 2). Results: Data from 482 patients were analyzed—229 patients (47.5%) [M:F = 1:1; median age: 60 (24–95) years] in group A and 253 patients (52.5%) [M:F = 1:1; median age: 71 (26–94) years] in group B. There was a significant difference between the two groups in grade distribution: 69.9% versus 38.3% for grade 0, 26.6% versus 51% for grade 1, and 3.5% versus 10.7% for grade 2 (p < 0.00001). In group A, severe sepsis (p = 0.027) was more common in higher grades of immunodeficiency. Patients with grade 2 needed longer hospitalization (p = 0.005). In group B, a similar condition was found in terms of severe sepsis (p = 0.002), quick Sequential Organ Failure Assessment score > 2 (p = 0.0002), and Mannheim Peritonitis Index (p = 0.010). A Hartmann’s procedure is mainly performed in grades 1–2 (p < 0.0001). Major complications increased significantly after a Hartmann’s procedure (p = 0.047). Mortality was higher in the immunocompromised patients (p = 0.002). Conclusions: Immunocompromised patients with acute diverticulitis present with a more severe clinical picture. When surgery is required, immunocompromised patients mainly undergo a Hartmann’s procedure. Postoperative morbidity and mortality are, however, higher in immunocompromised patients, who also require a longer hospital stay.
| File | Dimensione | Formato | |
|---|---|---|---|
|
tech in colonprocto 2023.pdf
Open access
Descrizione: paper
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
609.15 kB
Formato
Adobe PDF
|
609.15 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
